ANGELA STATHOPOULOS: Open Payments
NPI 1306096193 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 42 payments from 11 companies in 2025. Trend: 2023 $1,046 · 2024 $550 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $223 |
| Teva Pharmaceuticals USA, Inc. | 4 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| ABBVIE INC. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
Products named: Auvelity, AUSTEDO XR, FANAPT, VRAYLAR, CAPLYTA, REXULTI, LUMRYZ, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
